TITAN SECURITIES LIMITED's Insider Trades & SAST Disclosures
TITAN SECURITIES LIMITED's most recent trade in Titan Biotech Ltd. was a Acquisition of 17,000 Equity Shares done at an average price of Rs. 175.4 . Disclosure was reported to the exchange on March 4, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for TITAN SECURITIES LIMITED in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 04 Mar 2021 | 17,000 | 2,776,155 (33.59%) | 0.21% | 175.4 | 2,981,150 | 02 Mar 2021 02 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 03 Mar 2021 | 20,000 | 2,759,155 (33.39%) | 0.24% | 171.8 | 3,436,800 | 01 Mar 2021 01 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 01 Mar 2021 | 15,906 | 2,739,155 (33.15%) | 0.19% | 172.4 | 2,741,702 | 26 Feb 2021 26 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 26 Feb 2021 | 16,885 | 2,723,249 (32.95%) | 0.20% | 172.8 | 2,917,759 | 24 Feb 2021 25 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 24 Feb 2021 | 28,860 | 2,706,364 (32.75%) | 0.35% | 172.6 | 4,982,336 | 22 Feb 2021 23 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 08 Feb 2021 | 8,000 | 2,677,504 (32.40%) | 0.10% | 168.6 | 1,348,689 | 05 Feb 2021 05 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 05 Feb 2021 | 8,638 | 2,669,504 (32.30%) | 0.10% | 168.1 | 1,452,120 | 04 Feb 2021 04 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 04 Feb 2021 | 10,400 | 2,660,866 (32.20%) | 0.13% | 165.6 | 1,722,712 | 03 Feb 2021 03 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Titan Biotech | TITAN SECURITIES LIMITED | Promoter Group | Acquisition | 03 Feb 2021 | 10,000 | 2,650,466 (32.07%) | 0.12% | 168.5 | 1,684,675 | 02 Feb 2021 02 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.